Download presentation
Presentation is loading. Please wait.
1
Breaking Down Resistance
Cell Volume 159, Issue 3, (October 2014) DOI: /j.cell Copyright © Terms and Conditions
2
Unexpected signaling crosstalk underlies resistance to targeted therapy (Created by Caitlyn Webster; courtesy of Monique Dail and Kevin Shannon). Cell , DOI: ( /j.cell ) Copyright © Terms and Conditions
3
The tyrosine kinase inhibitor ponatinib (orange) binds to the ABL1T315I kinase domain (upper) but not ABLE255V/T315I (lower, point mutants in yellow) (Courtesy of Matthew Zabriskie and Nadeem Vellore). Cell , DOI: ( /j.cell ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.